Novel Aryl‐Modified Benzoylamino‐ N ‐(5,6‐dimethoxy‐1H‐benzoimidazol‐2‐yl)‐heteroamides as Potent Inhibitors of Vascular Endothelial Growth Factor Receptors 1 and 2-Reference-Cited by-同舟云学术

Novel Aryl‐Modified Benzoylamino‐ N ‐(5,6‐dimethoxy‐1H‐benzoimidazol‐2‐yl)‐heteroamides as Potent Inhibitors of Vascular Endothelial Growth Factor Receptors 1 and 2

Published:2016-12-11 Issue:3 Volume:54 Page:1949-1956
ISSN:0022-152X
Container-title:Journal of Heterocyclic Chemistry
language:en
Short-container-title:J. Heterocyclic Chem.

Author:

Ashok Abhishek¹,Thanukrishnan Kannan¹,Bhojya Naik Halehatty S.²,Maridu Rajendraswami¹

Affiliation:

1. Anthem Biosciences Pvt. Ltd. 49 Bommasandra Industrial Area, Bommasandra Bangalore 560099 Karnataka India

2. Department of PG Studies and Research in Industrial Chemistry, School of Chemical SciencesKuvempu University Shankaraghatta Karnataka 577451 India

Funder

Anthem Biosciences

Publisher

Wiley

Subject

Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhet.2791

Reference26 articles.

1. Heparan sulfate: a piece of information

2. Endothelial receptor tyrosine kinases involved in angiogenesis.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The medicinal panorama of benzimidazoles and their scaffolds as anticancer and antithrombotic agents: A review;Archiv der Pharmazie;2023-07-13

2. Design, Synthesis, and Molecular Modeling Studies of a Novel Benzimidazole as an Aromatase Inhibitor;ACS Omega;2022-04-28

3. Benzimidazole: A Multifacted Nucelus for Anticancer Agents;Current Organic Chemistry;2021-03-26

4. Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy;Future Journal of Pharmaceutical Sciences;2020-07-29